Literature DB >> 27861788

Phenotypically resembling myeloid derived suppressor cells are increased in children with HIV and exposed/infected with Mycobacterium tuberculosis.

Nelita Du Plessis1, Ruschca Jacobs1, Andrea Gutschmidt1, Zhuo Fang1, Paul D van Helden1, Manfred B Lutz2, Anneke C Hesseling3, Gerhard Walzl1.   

Abstract

Increased disease susceptibility during early life has been linked to immune immaturity, regulatory T-cell/TH2 immune biasing and hyporesponsiveness. The contribution of myeloid derived suppressor cells (MDSCs) remains uninvestigated. Here, we assessed peripheral MDSC in HIV-infected and -uninfected children with tuberculosis (TB) disease before, during and after TB treatment, along with matched household contacts (HHCs), HIV-exposed, -infected and -uninfected children without recent TB exposure. Serum analytes and enzymes associated with MDSC accumulation/activation/function were measured by colorimetric- and fluorescence arrays. Peripheral frequencies of cells phenotypically resembling MDSCs were significantly increased in HIV-exposed uninfected (HEU) and M.tb-infected children, but peaked in children with TB disease and remained high following treatment. MDSC in HIV-infected (HI) children were similar to unexposed uninfected controls; however, HAART-mediated MDSC restoration to control levels could not be disregarded. Increased MDSC frequencies in HHC coincided with enhanced indoleamine-pyrrole-2,3-dioxygenase (IDO), whereas increased MDSC in TB cases were linked to heightened IDO and arginase-1. Increased MDSC were paralleled by reduced plasma IP-10 and thrombospondin-2 levels in HEU and significantly increased plasma IL-6 in HI HHC. Current investigations into MDSC-targeted treatment strategies, together with functional analyses of MDSCs, could endorse these cells as novel innate immune regulatory mechanism of infant HIV/TB susceptibility.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Children; Early life immunity; HIV exposure; Myeloid derived suppressor cells (MDSCs); Tuberculosis

Mesh:

Substances:

Year:  2016        PMID: 27861788      PMCID: PMC5233566          DOI: 10.1002/eji.201646658

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  55 in total

1.  Altered immunological reactivity in HIV-1-exposed uninfected neonates.

Authors:  Joana Hygino; Patrícia G Lima; Renato G S Filho; Agostinho A L Silva; Carmen S M Saramago; Regis M Andrade; Daniel M Andrade; Arnaldo F B Andrade; Rodrigo Brindeiro; Amilcar Tanuri; Cleonice A M Bento
Journal:  Clin Immunol       Date:  2008-03-19       Impact factor: 3.969

Review 2.  Fetal regulatory T cells and peripheral immune tolerance in utero: implications for development and disease.

Authors:  Trevor D Burt
Journal:  Am J Reprod Immunol       Date:  2013-02-25       Impact factor: 3.886

Review 3.  Early life response to infection.

Authors:  Peter Ghazal; Paul Dickinson; Claire L Smith
Journal:  Curr Opin Infect Dis       Date:  2013-06       Impact factor: 4.915

4.  Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer.

Authors:  Ping-Ying Pan; Ge Ma; Kaare J Weber; Junko Ozao-Choy; George Wang; Bingjiao Yin; Celia M Divino; Shu-Hsia Chen
Journal:  Cancer Res       Date:  2009-12-08       Impact factor: 12.701

5.  Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells.

Authors:  Thomas Vollbrecht; Renate Stirner; Amanda Tufman; Julia Roider; Rudolf M Huber; Johannes R Bogner; Andreas Lechner; Carole Bourquin; Rika Draenert
Journal:  AIDS       Date:  2012-07-31       Impact factor: 4.177

6.  Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples.

Authors:  Athanasios Kotsakis; Malgorzata Harasymczuk; Bastian Schilling; Vasilis Georgoulias; Athanassios Argiris; Theresa L Whiteside
Journal:  J Immunol Methods       Date:  2012-04-13       Impact factor: 2.303

Review 7.  The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity.

Authors:  Je-In Youn; Dmitry I Gabrilovich
Journal:  Eur J Immunol       Date:  2010-11       Impact factor: 5.532

Review 8.  HIV-exposed uninfected children: a growing population with a vulnerable immune system?

Authors:  L Afran; M Garcia Knight; E Nduati; B C Urban; R S Heyderman; S L Rowland-Jones
Journal:  Clin Exp Immunol       Date:  2014-04       Impact factor: 4.330

9.  Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization.

Authors:  M Loetscher; P Loetscher; N Brass; E Meese; B Moser
Journal:  Eur J Immunol       Date:  1998-11       Impact factor: 5.532

10.  Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy.

Authors:  C Marcela Diaz-Montero; Mohamed Labib Salem; Michael I Nishimura; Elizabeth Garrett-Mayer; David J Cole; Alberto J Montero
Journal:  Cancer Immunol Immunother       Date:  2008-04-30       Impact factor: 6.968

View more
  17 in total

1.  Friends and foes of tuberculosis: modulation of protective immunity.

Authors:  S Brighenti; S A Joosten
Journal:  J Intern Med       Date:  2018-05-27       Impact factor: 8.989

2.  Heat-killed Mycobacterium tuberculosis prime-boost vaccination induces myeloid-derived suppressor cells with spleen dendritic cell-killing capability.

Authors:  Eliana Ribechini; Ina Eckert; Andreas Beilhack; Nelita Du Plessis; Gerhard Walzl; Ulrike Schleicher; Uwe Ritter; Manfred B Lutz
Journal:  JCI Insight       Date:  2019-06-04

3.  Evaluation of autophagy mediators in myeloid-derived suppressor cells during human tuberculosis.

Authors:  Leigh A Kotze; Vinzeigh N Leukes; Zhuo Fang; Manfred B Lutz; Bryna L Fitzgerald; John Belisle; Andre G Loxton; Gerhard Walzl; Nelita du Plessis
Journal:  Cell Immunol       Date:  2021-08-24       Impact factor: 4.178

4.  Harmful Effects of Granulocytic Myeloid-Derived Suppressor Cells on Tuberculosis Caused by Hypervirulent Mycobacteria.

Authors:  Caio César Barbosa Bomfim; Eduardo Pinheiro Amaral; Igor Santiago-Carvalho; Gislane Almeida Santos; Érika Machado Salles; Araceli Aparecida Hastreiter; Rogério Silva do Nascimento; Fabrício M Almeida; Thatiana Lopes Biá Ventura Simão; Andreza Linhares Rezende; Mario Hiroyuki Hirata; Ricardo Ambrósio Fock; José Maria Álvarez; Elena B Lasunskaia; Maria Regina D'Império Lima
Journal:  J Infect Dis       Date:  2021-02-13       Impact factor: 5.226

5.  Effective Host-Directed Therapy for Tuberculosis by Depletion of Myeloid-Derived Suppressor Cells and Related Cells Using a Diphtheria Toxin Fusion Protein.

Authors:  Sadiya Parveen; Shichun Lun; Michael E Urbanowski; Mitchell Cardin; Jessica Shen; John R Murphy; William R Bishai
Journal:  J Infect Dis       Date:  2021-12-01       Impact factor: 5.226

6.  PMN-MDSC Frequency Discriminates Active Versus Latent Tuberculosis and Could Play a Role in Counteracting the Immune-Mediated Lung Damage in Active Disease.

Authors:  Germana Grassi; Valentina Vanini; Federica De Santis; Alessandra Romagnoli; Alessandra Aiello; Rita Casetti; Eleonora Cimini; Veronica Bordoni; Stefania Notari; Gilda Cuzzi; Silvia Mosti; Gina Gualano; Fabrizio Palmieri; Maurizio Fraziano; Delia Goletti; Chiara Agrati; Alessandra Sacchi
Journal:  Front Immunol       Date:  2021-04-26       Impact factor: 7.561

Review 7.  Monocytic Myeloid-Derived Suppressor Cells in Chronic Infections.

Authors:  Anca Dorhoi; Nelita Du Plessis
Journal:  Front Immunol       Date:  2018-01-04       Impact factor: 7.561

Review 8.  Paradoxes in the Phenotype, Frequency and Roles of Myeloid-Derived Suppressor Cells During HIV Infection.

Authors:  Muluneh Ademe
Journal:  HIV AIDS (Auckl)       Date:  2020-04-14

9.  Moving toward Tuberculosis Elimination. Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection.

Authors:  Salmaan Keshavjee; Farhana Amanullah; Adithya Cattamanchi; Richard Chaisson; Karen M Dobos; Gregory J Fox; Howard E Gendelman; Richard Gordon; Anneke Hesseling; Hoi Le Van; Beate Kampmann; Bavesh Kana; Gopal Khuller; David M Lewinsohn; Deborah A Lewinsohn; Philiana Ling Lin; Lenette Lin Lu; Gary Maartens; Andrew Owen; Marina Protopopova; Jyothi Rengarajan; Eric Rubin; Padmini Salgame; Erwin Schurr; James A Seddon; Susan Swindells; David M Tobin; Zarir Udwadia; Gerhard Walzl; Sudha Srinivasan; Roxana Rustomjee; Payam Nahid
Journal:  Am J Respir Crit Care Med       Date:  2019-03-01       Impact factor: 21.405

10.  The Frequency and Effect of Granulocytic Myeloid-Derived Suppressor Cells on Mycobacterial Survival in Patients With Tuberculosis: A Preliminary Report.

Authors:  Malika Davids; Anil Pooran; Liezel Smith; Michele Tomasicchio; Keertan Dheda
Journal:  Front Immunol       Date:  2021-06-01       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.